Medacta International SA, headquartered in Switzerland (CH), is a leading player in the global medical device industry, specialising in orthopaedic and spinal surgery solutions. Founded in 1999, the company has established a strong presence in key operational regions, including Europe, North America, and Asia.
Medacta is renowned for its innovative products, such as the M.O.R.E. (Medacta Orthopaedic Research and Education) programme, which enhances surgical techniques and patient outcomes. The company’s commitment to advanced technology and minimally invasive procedures sets it apart in the competitive landscape.
With a focus on quality and precision, Medacta has achieved significant milestones, including numerous regulatory approvals and a growing portfolio of patented technologies. Its dedication to improving surgical performance and patient care solidifies its position as a trusted name in orthopaedics and spinal surgery.
-9 vs industry average
Medacta’s score of 23 is lower than 41% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Medacta?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Business Services has below-average carbon intensity
Industry performance
The Business Services industry has increased its overall emissions by 24% since 2019
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Medacta's reported carbon emissions
In 2025, Medacta reported total emissions of approximately 2,547,000 kg CO2e, comprising 1,480,000 kg CO2e from Scope 1 and 1,067,000 kg CO2e from Scope 2 emissions. In 2024, the company recorded total emissions of about 1,916,000 kg CO2e, with Scope 1 emissions at 1,296,000 kg CO2e and Scope 2 emissions at 620,000 kg CO2e. For 2023, Medacta's emissions were approximately 1,458,000 kg CO2e, including 949,000 kg CO2e from Scope 1 and 509,000 kg CO2e from Scope 2. Despite these figures, Medacta has not set specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or commitments to frameworks such as the Science Based Targets initiative (SBTi). The company does not currently disclose any Scope 3 emissions data, which includes emissions from purchased goods and services, business travel, and employee commuting. Medacta's emissions data is not cascaded from a parent company, and all reported figures are directly attributed to Medacta Group SA. The company is headquartered in Switzerland (CH) and continues to focus on sustainability within its operational framework.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Medacta’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Medacta yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Medacta
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project